Key Points. Langerhans cell histiocytosis is a rare disorder that can damage tissue or cause lesions to form in one or more places in the body. It is not known whether LCH is a form of cancer or a cancer-like disease.
Langerhans cell histiocytosis historically was thought of as a cancer-like condition, but more recently researchers have begun to consider it an autoimmune phenomenon in which immune cells begin to overproduce and attack the body instead of fighting infection.
Listen to pronunciation. (HIS-tee-oh-sy-TOH-sis) A group of rare disorders in which too many histiocytes (a type of white blood cell) build up in certain tissues and organs, including the skin, bones, spleen, liver, lungs, and lymph nodes.
The exact cause of histiocytosis is unknown. However, recent studies indicate that it is caused by the development and expansion of an abnormal Langerhans cell that subsequently leads to the accumulation of other cells of the immune system, resulting in collections or tumors in various areas of the body.
Langerhans cell histiocytosis is a rare disorder that can affect people of all ages. The highest rate is among children ages 5 to 10. Some forms of the disorder are genetic, which means they are inherited.
A histiocytosis is a disease in which there are too many histiocyte cells in the skin and other organs. Normal histiocyte cells are part of the immune system, alerting infection-fighting cells to the presence of foreign material such as bacteria (antigen presentation).
Definition. L&H cells are the tumor cells in the lymphocyte predominant subtype of Hodgkin lymphoma. These are relatively large mononuclear lymphoma B cells, showing strong expression of the B cell maker CD20. Hodgkin and Reed/Sternberg Cell.
DCs, monocytes, and macrophages are members of the mononuclear phagocyte system,2 whereas a histiocyte is a morphological term referring to tissue-resident macrophages. Macrophages are large ovoid cells mainly involved in the clearance of apoptotic cells, debris, and pathogens.
Radiology Scans CT scans can identify areas of histiocytosis. They can be used to look at any part of the body, but CT is most helpful for detecting histiocytosis in the lungs, heart, kidneys, lymph nodes, and other organs. MRI scans can get a very detailed picture of certain organs.
Histiocytosis is a general name for a group of disorders or "syndromes" that involve an abnormal increase in the number of specialized white blood cells that are called histiocytes.
Langerhans cell histiocytosis (LCH) is a rare, cancer-like condition. It happens when a person's body makes too many immature Langerhans cells. These cells are a type of immune cell known as histiocytes.
Langerhans cell histiocytosis (LCH) in adults is a rare disorder that occurs when the body produces too many Langerhans cells (histiocytes), which are a type of white blood cell that helps fight infection.
histiocytic lymphoma a rare type of non-Hodgkin's lymphoma of intermediate to high malignancy, characterized by large tumor cells that resemble histiocytes morphologically but are considered to be of lymphoid origin.
epidermisLangerhans cells (LC) are a unique population of tissue-resident macrophages that form a network of cells across the epidermis of the skin, but which have the ability to migrate from the epidermis to draining lymph nodes (LN). Their location at the skin barrier suggests a key role as immune sentinels.
In a small subset of patients, LCH has been identified as an incidental finding in biopsy specimens involved by lymphoma. Classical Hodgkin lymphoma is the most common associated lymphoma,23–26 whereas only sporadic cases of other types of non-Hodgkin lymphoma associated with LCH are reported in the literature.
Langerhans cell histiocytosis (LCH) is a rare disorder of histiocyte proliferation. Previous case studies suggest a higher prevalence of hematologic and solid malignancies among LCH patients, possibly due to treatment with tumorigenic agents such as etoposide.
Systemic (body-wide) histiocytosis is a chronic, debilitating disease usually in young Bernese Mountain Dogs. It has a fluctuating course with lumps affecting the skin, lymph nodes, eyes, and other tissues. It is rarely fatal although it is a progressive disease.
Sinus histiocytosis is a common feature in lymph node biopsies and is characterized by dilated lymph node sinuses containing variable numbers of histiocytes, with bland, indented nuclei and eosinophilic cytoplasm (Figure 1A).
Histiocytic sarcoma (HS) is a rare neoplasia(1-7) of hematopoietic origin characterized by the proliferation of malignant cells that have the morphological and immunohistochemical characteristics of mature tissue histiocytes.
The prognosis for children with LCH is generally excellent. The disease is rarely life-threatening. However, some LCH survivors experience long-term effects, such as orthopedic disabilities, hearing impairment, diabetes insipidus, and skin scarring.
When cells are making too many copies of themselves, this causes LCH lesions to grow. There is a specific gene called BRAF that has a mutation in about one half of LCH tumors. Recent research has identified other genes with mutations in LCH lesions but this requires further research.
Localized histiocytic sarcoma is sometimes more slowly progressive, but can be extremely painful and cause a poor quality of life. Overall, response rates to treatment are poor and survival times are short (3-4 months). The prognosis for hemophagocytic histiocytic sarcoma is considered grave (< 2months.)
Radiology Scans CT scans can identify areas of histiocytosis. They can be used to look at any part of the body, but CT is most helpful for detecting histiocytosis in the lungs, heart, kidneys, lymph nodes, and other organs. MRI scans can get a very detailed picture of certain organs.
Clinical Information. A clinical variant of langerhans cell histiocytosis characterised by unifocal involvement of a bone (most often), skin, or lung. Patients are usually older children or adults usually presenting with a lytic bone lesion. The etiology is unknown.
There is involvement of multiple organ systems including the bones, skin, liver, spleen, and lymph nodes.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as C96.6. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
The most benign and common form of langerhans-cell histiocytosis which involves localized nodular lesions predominantly of the bones but also of the gastric mucosa, small intestine, lungs, or skin, with infiltration by eosinophils.
Most benign clinical form of langerhans-cell histiocytosis, which involves localized nodular lesions of the gastric mucosa, small intestine, bones, lungs, or skin, with infiltration by eosinophils; the proliferating cell that appears to be responsible for the clinical manifestations is the langerhans cell .
In the past, cases of anaplastic large cells lymphoma were called malignant histiocytosis.
Malignant neoplasms composed of macrophages or dendritic cells. Most histiocytic sarcomas present as localized tumor masses without a leukemic phase. Though the biological behavior of these neoplasms resemble lymphomas, their cell lineage is histiocytic not lymphoid.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Functional activity. All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology]
The 2022 edition of ICD-10-CM C96.A became effective on October 1, 2021.
In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.